Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?

The fascinating similarity between the SARS-CoV and SARS-CoV-2, inspires scientific community to investigate deeper into the SARS-CoV proteases such as main protease (Mpro) and papain-like protease (PLpro) and their inhibitors for the discovery of SARS-CoV-2 protease inhibitors. Because of the simil...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Sk Abdul, Banerjee, Suvankar, Gayen, Shovanlal, Jha, Tarun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880840/
https://www.ncbi.nlm.nih.gov/pubmed/33618158
http://dx.doi.org/10.1016/j.ejmech.2021.113294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880840/
https://www.ncbi.nlm.nih.gov/pubmed/33618158
http://dx.doi.org/10.1016/j.ejmech.2021.113294

Ejemplares similares